The latest closing stock price for Dianthus Therapeutics as of February 21, 2025 is 23.67.
An investor who bought $1,000 worth of Dianthus Therapeutics stock at the IPO in 2018 would have $-898 today, roughly -1 times their original investment - a -27.84% compound annual growth rate over 7 years.
The all-time high Dianthus Therapeutics stock closing price was 315.20 on March 25, 2019.
The Dianthus Therapeutics 52-week high stock price is 33.77, which is 42.7% above the current share price.
The Dianthus Therapeutics 52-week low stock price is 18.34, which is 22.5% below the current share price.
The average Dianthus Therapeutics stock price for the last 52 weeks is 25.57.
An investor who bought $1,000 worth of Dianthus Therapeutics stock at the IPO in 2018 would have $-898 today, roughly -1 times their original investment - a -27.84% compound annual growth rate over 7 years.
The all-time high Dianthus Therapeutics stock closing price was 315.20 on March 25, 2019.
The Dianthus Therapeutics 52-week high stock price is 33.77, which is 42.7% above the current share price.
The Dianthus Therapeutics 52-week low stock price is 18.34, which is 22.5% below the current share price.
The average Dianthus Therapeutics stock price for the last 52 weeks is 25.57.